脂肪移植后癌症风险:多中心病例队列研究
该多中心病例队列研究评估乳房切除术后即刻再造中脂肪移植与癌症复发的关系。研究纳入2006至2011年间四中心接受乳房切除即刻再造的浸润性乳腺癌女性患者,复发为病例,30%随机样本为对照。结果显示脂肪移植未增加癌症复发风险。
要点
- 脂肪移植与乳腺癌复发无显著关联
- 未调整风险比为0.99,调整后为0.97
- 研究证据等级为治疗性III级
核心结论
- 在乳房切除即刻再造的乳腺癌患者中,脂肪移植与癌症复发风险升高无关。
研究设计与样本
- 多中心病例队列研究,纳入四中心2006至2011年间接受乳房切除即刻再造、年龄大于21岁的女性浸润性导管癌(I-III期)患者。
- 病例为研究期间所有复发患者,对照为研究人群的30%随机样本。
主要发现
- 脂肪移植未调整的疾病复发时间风险比为0.99(95%CI 0.56-1.7)。
- 调整年龄、体重指数、分期、HER2/Neu受体状态和雌激素受体状态后,风险比为0.97(95%CI 0.54-1.8)。
临床怎么用
- 对于接受乳房切除即刻再造的乳腺癌患者,脂肪移植可考虑用于优化再造效果,不增加复发风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Fat transfer is an increasingly popular method for refining postmastectomy breast reconstructions. However, concern persists that fat transfer may promote disease recurrence. Adipocytes are derived from adipose-derived stem cells and express adipocytokines that can facilitate active breast cancer cells in laboratory models. The authors sought to evaluate the association between fat transfer to the reconstructed breast and cancer recurrence in patients diagnosed with local or regional invasive breast cancers. METHODS: A multicenter, case-cohort study was performed. Eligible patients from four centers (Memorial Sloan Kettering, M. D. Anderson Cancer Center, Alvin J. Siteman Cancer Center, and the University of Chicago) were identified by each site's institutional tumor registry or cancer data warehouse. Eligibility criteria were as follows: mastectomy with immediate breast reconstruction between 2006 and 2011, age older than 21 years, female sex, and incident diagnosis of invasive ductal carcinoma (stage I, II, or III). Cases consisted of all recurrences during the study period, and controls consisted of a 30 percent random sample of the study population. Cox proportional hazards regression was used to evaluate for association between fat transfer and time to recurrence in bivariate and multivariate models. RESULTS: The time to disease recurrence unadjusted hazard ratio for fat transfer was 0.99 (95 percent CI, 0.56 to 1.7). After adjustment for age, body mass index, stage, HER2/Neu receptor status, and estrogen receptor status, the hazard ratio was 0.97 (95 percent CI, 0.54 to 1.8). CONCLUSION: In this population of breast cancer patients who had mastectomy with immediate reconstruction, fat transfer was not associated with a higher risk of cancer recurrence. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, III.
引用
- Myckatyn TM, Wagner IJ, Mehrara BJ, et al. Cancer Risk after Fat Transfer: A Multicenter Case-Cohort Study. Plast Reconstr Surg. 2017. PMID: 28027219. doi:10.1097/PRS.0000000000002838
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。